Novo Nordisk Shares Drop After
Photo: Johan Nilsson / TT

Novo Nordisk Shares Drop After Trump Comments on Ozempic Pricing

The Danish pharmaceutical giant Novo Nordisk's share falls after Donald Trump has expressed himself about the price of Ozempic.

Advertisement

The President of the USA, Donald Trump, promised at a press conference on Thursday that the price of the weight loss medicine Ozempic would be significantly reduced in the USA.

This makes the company's share fall on the Copenhagen Stock Exchange, after lunch the share is down by nearly 6 percent.

Also the American competitor Eli Lilly is falling back, the share is down by around 4 percent in the preliminary negotiations.

In this story
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All